PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31196753-0	2019	Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent beta-glucuronidase inhibitors and their molecular docking study.	Oxadiazoles	13-23	glucuronidase beta	Homo sapiens	68-86	
31196753-1	2019	A new series of oxadiazole with thiadiazole moiety (6-27) were synthesized, characterized by different spectroscopic techniques and evaluated for beta-glucuronidase inhibitory potential.	Oxadiazoles	16-26	glucuronidase beta	Homo sapiens	146-164	
31003424-0	2019	Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent beta-Glucuronidase Inhibitors.	Oxadiazoles	27-37	glucuronidase beta	Homo sapiens	68-86	
31003424-1	2019	Chromen-4-one substituted oxadiazole analogs 1-19 have been synthesized, characterized and evaluated for beta-glucuronidase inhibition.	Oxadiazoles	26-36	glucuronidase beta	Homo sapiens	105-123	
26526743-0	2015	Synthesis of novel benzohydrazone-oxadiazole hybrids as beta-glucuronidase inhibitors and molecular modeling studies.	Oxadiazoles	34-44	glucuronidase beta	Homo sapiens	56-74	
28160943-0	2017	Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As beta-glucuronidase inhibitors.	Oxadiazoles	61-71	glucuronidase beta	Homo sapiens	81-99	
30857263-4	2019	Twenty-two (1-22) analogs of indole based oxadiazole were synthesized and screened for their inhibitory potential against beta-glucuronidase.	Oxadiazoles	42-52	glucuronidase beta	Homo sapiens	122-140